HOME
LOGIN
THE MEDICAL LETTER
Subscribe
Current Issue
Previous Issues
Reference Tables
ABOUT US
The Medical Letter, Inc.
CONTINUING EDUCATION
Exams
DRUG INTERACTIONS
CONTACT US
The Medical Letter Mobile Home Page
CURRENT
ISSUE
1572
The FDA has approved Inbrija (Acorda), an orally inhaled dry-powder formulation of levodopa, for intermittent treatment of "off" episodes in patients with Parkinson's disease (PD) being treated with carbidopa/levodopa (Sinemet, and others).  read more...
More from issue 1572
Coming Soon
Drugs for Psoriasis
Romosozumab (Evenity) for Postmenopausal Osteoporosis
Prucalopride (Motegrity) for Chronic Idiopathic Constipation
Risankizumab (Skyrizi) for Psoriasis
Tafenoquine (Arakoda and Krintafel) for Malaria
Recommend to Your Library  

We're Essential.   Begin your free trial  
Previous Issues
© 2019 The Medical Letter, Inc.